Topical Timolol for Infantile Hemangiomas: Evidence for Efficacy and Degree of Systemic Absorption
- 3 February 2016
- journal article
- Published by Wiley in Pediatric Dermatology
- Vol. 33 (2) , 184-190
Abstract
Background: Topical use of timolol for infantile hemangiomas has recently emerged with promising results. It is unknown whether topical β‐blockers act locally or if their effect is partly due to systemic absorption. This study investigates whether topically applied timolol is absorbed and reports on the efficacy of this treatment.Methods: We treated 40 infants with small proliferating hemangiomas with topical timolol gel 0.5% twice daily and assessed urinary excretion and serum levels in a proportion of patients. Clinical response was evaluated on a visual analog scale of standardized photographs after 1, 2, 3, and 5 months.Results: Forty infants with a median age of 18 weeks (range 2–35 wks) were included; 23 (58%) had superficial and 17 (42%) mixed‐type hemangiomas. The median size was 3 cm2 (range 0.1–15 cm2) and nine hemangiomas were ulcerated. The hemangiomas improved significantly during treatment, with a median increase in visual analog scale of 7 points after 5 months (p < 0.001). Urinalysis for timolol was performed in 24 patients and was positive in 20 patients (83%). In three infants, serum levels of timolol were also measured and were all positive (median 0.16 ng/mL [range 0.1–0.18 ng/mL]). No significant side effects were recorded.Conclusion: Topical therapy with timolol is effective for infantile hemangiomas, but systemic absorption occurs. Serum levels in our patients were low, suggesting that using timolol for small hemangiomas is safe, but caution is advised when treating ulcerated or large hemangiomas, very young infants, or concomitantly using systemic propranolol.Keywords
This publication has 29 references indexed in Scilit:
- RCT of Timolol Maleate Gel for Superficial Infantile Hemangiomas in 5- to 24-Week-OldsPediatrics, 2013
- A Controlled Study of Topical 0.25% Timolol Maleate Gel for the Treatment of Cutaneous Infantile Capillary HemangiomasOphthalmic Plastic & Reconstructive Surgery, 2012
- Topical Timolol for Infantile Hemangiomas: Putting a Note of Caution in “Cautiously Optimistic”Pediatric Dermatology, 2012
- Treatment of Small Superficial Haemangioma with Timolol 0.5% Ophthalmic Solution: A Series of 20 CasesDermatology, 2011
- Timolol Maleate 0.5% or 0.1% Gel‐Forming Solution for Infantile Hemangiomas: A Retrospective, Multicenter, Cohort StudyPediatric Dermatology, 2011
- Topical Propranolol Therapy for Infantile HemangiomasPediatric Dermatology, 2011
- A Prospective Study of Infantile Hemangiomas with a Focus on Incidence and Risk FactorsPediatric Dermatology, 2011
- Efficacy and safety of propranolol as first-line treatment for infantile hemangiomasEuropean Journal of Pediatrics, 2010
- Propranolol for Severe Hemangiomas of InfancyNew England Journal of Medicine, 2008
- Ophthalmic timolol: Plasma concentration and systemic cardiopulmonary effectsScandinavian Journal of Clinical and Laboratory Investigation, 2007